We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App





QuidelOrtho Presents Flexible Solutions for Quality Diagnostic Results Across Healthcare Continuum

By LabMedica International staff writers
Posted on 30 Jul 2025

QuidelOrtho Corporation (San Diego, CA, USA) is demonstrating its advanced diagnostic laboratory solutions and participating in a featured ADLM session on how Six Sigma insights can improve lab performance. More...

At ADLM 2025, QuidelOrtho is demonstrating how its flexible and reliable solutions can deliver quality diagnostic results across the entire healthcare continuum – from home to hospital, lab to clinic. QuidelOrtho is highlighting its VITROS Automation Solutions, which, combined with VITROS chemistry and immunoassay systems, can deliver high-quality results faster than VITROS systems alone. QuidelOrtho is also showcasing the VITROS XT 7600 Integrated system, which offers a full clinical chemistry and immunoassay menu in one easy-to-use system that delivers industry-leading uptime. Built-in technologies improve efficiency and quality, allowing for scalable automation solutions that streamline laboratory workflow. Additionally, QuidelOrtho is highlighting the VITROS XT 3400 system, which is powered by intelligent technologies and digital imaging technology to help labs meet routine testing needs and deliver proven high-quality results and system reliability in a small footprint.

Also featuring at this year’s ADLM is the Ortho Vision Max Swift automated immunohematology system, which can automate more than 99% of blood typing and antibody screening, without compromising turnaround time. Alongside, QuidelOrtho is featuring the Sofia 2 fluorescent immunoassay analyzer, built around the company’s proprietary fluorescence technology detection with an ultraviolet LED energy source. An optical sensor inside Sofia quickly scans and reliably collects hundreds of data points to generate actionable test results for the disease targets labs are seeking. QuidelOrtho is also highlighting its easy-to-use Quidel Triage system that provides the reliable diagnostic answers needed to make rapid, cost-effective treatment decisions at the point-of-care. With its comprehensive menu, the Quidel Triage system delivers lab-quality results at point-of-care speed.

Additionally, in a featured session at the ADLM meeting, QuidelOrtho and a panel of experts will be sharing how the company’s Six Sigma tools and real lab data can drive quality outcomes. For over 35 years, Six Sigma methodology and strategies have been used by businesses to improve manufacturing and operational quality and minimize variability. Sigma metrics have been adapted for the clinical laboratory by incorporating observed accuracy, precision, and total error allowed (TEa). Sigma metrics offer a valuable approach to quantifying quality. A higher sigma value corresponds to greater accuracy and precision in the measurements of processes being evaluated.

Related Links:
QuidelOrtho Corporation


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic Hematology Analyzer
LABAS F9000
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.